Business Context and Reporting Period
Company: Brookdale Senior Living Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 20, 2006
Event Date: July 19, 2006
Context: The Company entered into a material definitive underwriting agreement to conduct a public offering of common stock.
Key Financial Metrics and Transaction Details
This filing details a capital raising event rather than periodic financial performance. Key transaction metrics include:
- Shares Offered: 19,236,103 shares of common stock (par value $0.01 per share).
- Offering Price: $39.50 per share.
- Share Allocation:
- 17,721,519 shares from the Company.
- 1,514,584 shares from Health Partners (an affiliate of Capital Z Partners and a stockholder).
- Over-Allotment Option: Underwriters granted a 30-day option to purchase an additional 2,885,415 shares from Health Partners.
- Expected Issuance Date: July 25, 2006.
Financial Performance: The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures for the reporting period.
Material Changes Versus Prior Period
The filing does not present comparative financial data or operational changes versus a prior period. The material change reported is the execution of the underwriting agreement and the subsequent public offering of equity.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release (Exhibit 99.1) announcing the pricing of the offering. No specific forward-looking guidance or outlook regarding future earnings or operations is included in this text.
Risks and Contingencies:
- The issuance of shares is subject to the terms and conditions of the Underwriting Agreement.
- The Company has agreed to indemnify underwriters against liabilities under the Securities Act of 1933 or contribute to payments required by underwriters.
- The transaction includes customary representations, warranties, and closing conditions.
Important Facts for Investor Verification
- Verify the final closing date and actual proceeds received, as issuance is subject to closing conditions.
- Confirm whether the underwriters exercised the 30-day over-allotment option for the additional 2,885,415 shares.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific underwriting discounts and commissions not detailed in this summary.
- Assess the dilution impact of the 17,721,519 new shares issued by the Company on existing shareholders.